Insider Shareholders with Direct Ownership of Eton Pharmaceuticals, Inc. (ETON)
This section provides a comprehensive overview of the insiders with direct ownership of Eton Pharmaceuticals, Inc. (ETON). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Eton Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sean Brynjelsen
President & CEO |
25,000 | 210,000 | 2,873,513 $44.9 Million | 6 |
Jun 05, 2025
Reduced 2.38%
|
|
Harrow Health, Inc.
> 10% Shareholder |
0 | 1,518,000 | 1,982,000 $30.9 Million | 1 |
Apr 12, 2021
Reduced 43.37%
|
|
David Krempa
Chief Business Officer |
0 | 34,000 | 612,646 $9.56 Million | 3 |
Jun 16, 2025
Reduced 1.64%
|
|
Norbert G Riedel
Director |
102,400 | 0 | 162,145 $2.53 Million | 1 |
Jan 03, 2025
Added 13.36%
|
|
William Wilson Troutman
CFO and Secretary |
5,000 | 0 | 23,027 $359,451 | 1 |
Aug 20, 2021
Added 17.84%
|